Day: March 22, 2022
Carnival Corp. CL, -0.60% said Tuesday it lost $1.89 billion, or $1.66 a share in the first quarter, compared to a loss of $1.97 billion, or $1.80 a share, in the year-ago period. Revenue increased to $1.62 billion from $26 million. Analysts expected a loss of $1.28 a share and revenue of $2.26 billion, according […]
Packaging company Sonoco Products co. SON, -1.12% raised its first-quarter guidance on Tuesday to reflect strong price and cost recovery across most of its businesses. The company said it expects per-share earnings of 80 cents to 90 cents, including after- tax restructuring charges and acquisition costs and other one-time items. Adjusted to remove those items, […]
This press release is not available in English. Please consult the French or Dutch site. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in Arseus NV , ISIN BE0003874915 on Euronext Brussels is suspended from 11/12/2014 at 16:58 PM until the publication of a press release. Trading will resume on 12/02/2014 at […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 7, § 3, OF THE LAW OF 2 AUGUST 2002 Trading in Aedifica , ISIN BE0003851681 on Euronext Brussels will re-open on 5/12/2014 at 11:15 AM. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 7, § 3, OF THE LAW OF 2 AUGUST 2002 Trading in WDP, ISIN BE0003763779 on Euronext Brussels will re-open on 20/11/2014 at 09:00 AM. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in WDP-Sicafi, ISIN BE0003763779 on Euronext Brussels is suspended on the request of the company from 19/11/2014 at 4:30 PM until the publication of the results of an accelerated […]
A Food and Drug Administration advisory committee is scheduled to meet April 6 to discuss whether there is a need to authorize or approve COVID-19 booster doses in the future. The Vaccines and Related Biological Products Advisory Committee will also talk about creating a process for selecting SARS-CoV-2 virus strains to be included in future […]
